Physician profile
Jason Murry
NPI 1184851040
$1,434.85
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $362 · 2021: $154 · 2022: $613 · 2023: $180 · 2024: $23.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $416.78 | 2019-2020 | |
| Tela Bio, INC. | $363.91 | 2022 | |
| My01 INC. | $143.16 | 2022 | |
| Medtronic, INC. | $132.31 | 2023 | Ligasure |
| Kci USA, INC. | $114.06 | 2021 | |
| Davol INC. | $105.70 | 2022 | |
| Acera Surgical, INC. | $66.29 | 2021-2023 | Restrata Wound Matrix |
| Misonix INC | $47.97 | 2020 | |
| Haemonetics Corporation | $23.03 | 2024 | Teg6s Hemostasis System |
| Astrazeneca Pharmaceuticals LP | $21.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Murry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.